Drug intelligence / Profile preview

Qingying Powder

Development stage: Unknown
Lead developer: Shanghai Municipal Hospital of Traditional Chinese Medicine
Administration: Oral

Overview

Qingying Powder is a Traditional Chinese Medicine (TCM) herbal formula presented in powder form. It is currently being investigated in clinical trials for its potential therapeutic effects in Hashimoto thyroiditis, specifically in patients with normal thyroid function. In TCM, formulas like Qingying Powder are typically composed of multiple herbs designed to address specific patterns of imbalance in the body, such as resolving phlegm, dissipating masses, clearing heat, and regulating qi and blood flow, which are common approaches to treating thyroid-related conditions. [3, 10]

Other names: 清瘿散

Targets

ADGRV1 (Adhesion G protein-coupled receptor V1)SYK (Spleen Tyrosine Kinase)

Beyond the preview

Go deeper on Qingying Powder.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Qingying Powder.

Explore the full profile